Distribution of Bamlanivimab/Etesevimab Paused in Several States

June 2, 2021 | Strategic Insights for Health System


​What's the news. Distribution of the monoclonal antibody combination of& bamlanivimab and etesevimab, authorized for emergency use treatment of COVID-19, has been paused in multiple states where the spread of certain SARS-CoV-2 variants is high, the Assistant Secretary for Preparedness and Response (ASPR), U.S. Department of Health and Human Services, said in a May 26, 2021, announcement.

Access Full Content

Contact us today at 610.825.6000.